Tobacco plants transformed into 'green bioreactors' to benefit human health

Tobacco plants transformed into 'green bioreactors' to benefit human health
Researchers at Western University and Lawson Health Research Institute are using tobacco plants as 'green bioreactors' to produce an anti-inflammatory protein with powerful therapeutic potential. Credit: Schulich Medicine & Dentistry, Western University

Researchers at Western University and Lawson Health Research Institute are using tobacco plants as 'green bioreactors' to produce an anti-inflammatory protein with powerful therapeutic potential.

The are being used to produce large quantities of a human protein called Interleukin 37, or IL-37. The protein is naturally produced in the human kidney in very small quantities and has powerful anti-inflammatory and immune-suppressing properties, providing potential for treating a number of inflammatory and like type 2 diabetes, stroke, dementia and arthritis.

"This protein is a master regulator of inflammation in the body, and has been shown in pre-clinical models to be effective in treating a whole host of diseases," said Dr. Tony Jevnikar, Professor at Western's Schulich School of Medicine & Dentistry and Scientist at Lawson. "The human kidney produces IL-37, but not nearly enough to get us out of an inflammation injury."

And while showing promise in animal models, IL-37's use clinically has been limited because of the inability to produce it in large quantities at a price that is feasible clinically. Currently, it can be made in very small amounts using the bacteria E. coli, but at a very high cost.

That's where the come in.

This work is the first of its kind to demonstrate that this functional human protein can be produced in plant cells. "The plants offer the potential to produce pharmaceuticals in a way that is much more affordable than current methods," said Shengwu Ma, Ph.D., Adjunct Professor in the Department of Biology at Western and Scientist at Lawson. "Tobacco is high-yield, and we can temporarily transform the plant so that we can begin making the protein of interest within two weeks."

The researchers have shown in a recent study published in the journal Plant Cell Reports, that the protein can be extracted and quantified from the plant cells in a way that maintains its function. Now that they've shown they can produce the in tobacco, it can be translated to other plants, like potatoes.

Dr. Jevnikar is investigating the effect that IL-37 has for preventing organ injury during transplantation. When an organ is removed for transplantation and then transferred to a recipient, inflammation occurs when the blood flow is restored to the organ. He and his team believe IL-37 provides a way to prevent that injury.

"I hope that this work will impact a change in how people view plants and hopefully this approach will be a way to provide treatments to patients that are effective and affordable," Dr. Jevnikar said.


Explore further

Regulating the MS-causing properties of Th17 cells

More information: Nadiyah Alqazlan et al, Production of functional human interleukin 37 using plants, Plant Cell Reports (2019). DOI: 10.1007/s00299-019-02377-2
Citation: Tobacco plants transformed into 'green bioreactors' to benefit human health (2019, February 26) retrieved 25 April 2019 from https://phys.org/news/2019-02-tobacco-green-bioreactors-benefit-human.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
10 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more